![]() |
Provider Price: from 7,95€ |
![]() |
Languages: DE, EN, FR, ES, IT, NL |
![]() |
Retention Time: 976 days |
In just six years, UseNeXT has grown into the largest European Usenet provider. UseNeXT has been active on the market since 2005 and offers its customers six download packages with varying data volumes. Munich-based UseNeXT places a particularly strong focus on customer support. In fact, this level of service is quite unique in a comparison of all providers. There are three ways of having your support questions answered: Visiting the FAQs section on the website, filling out a comprehensive online question form and calling a 24/7 telephone hotline, available all year round. The retention time for binary files is 810 days, with text files even retained for 1500 days. One particularly interesting feature offered by UseNeXT is the HybridRate, which enables users to download up to 600 GB every month for free.
| UseNeXT | Result |
| Downloadspeed | DSL Highspeed |
| Retention Time | 976 days |
| Free Trial | 14-day trial |
| Packages | |
| Tarif 30+ | 7,95€ |
| Tarif 80+ | 9,95€ |
| Tarif 250+ | 19,95€ |
| Languages | DE, EN, FR, ES, IT, NL |
| Own Software | Tangysoft Newsreader |
| Support | 24/7 Online, Telephone |
| Place of Business | Germany |
| Other | Hybrid Rate |
It is no surprise that UseNeXT is the leading European Usenet provider on the market, given the range of features it has to offer. The outstanding commitment to customer service with 24/7 active support truly underlines the Munich-based company's dedication to quality. As is typical for European Usenet providers, the website is also available in multiple languages. This enables German, English, French, Spanish, Italian and Dutch speaking customers to easily find their way onto the Usenet via UseNeXT. In line with its full service commitment, UseNeXT also provides its customers with a free newsreader, which is available in nine languages, on conclusion of contract. Potential customers can also extensively test UseNeXT with a free 14 day trial.